Hitoshi Kiyoi

15.2k citations

277 papers · 9.0k indexed · 1 hit paper · h-index 46

Impact in

Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 174
- Acute Myeloid Leukemia Research 114
- Chronic Myeloid Leukemia Treatments 69
- Hematopoietic Stem Cell Transplantation 26
Genetics 61
- Chronic Lymphocytic Leukemia Research 35

Co-authors: Tomoki Naoe Hidehiko Saito T Naoe Fumihiko Hayakawa Masayuki Towatari Ryuzo Ueda Akihiro Tomita Ryuzo Ohno
Journals: Blood (50 papers)International Journal of Hematology (32 papers)Leukemia (23 papers)Cancer Science (21 papers)British Journal of Haematology (9 papers)
Partner nations: Japan United States Germany

In The Last Decade

Hitoshi Kiyoi

265 papers receiving 8.8k citations

Hit Papers

align trajectories log scale

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. 1999 · 620 citations

Peers

Countries citing papers authored by Hitoshi Kiyoi

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Kiyoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Kiyoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Kiyoi more than expected).

Fields of papers citing papers by Hitoshi Kiyoi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Kiyoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Kiyoi. The network helps show where Hitoshi Kiyoi may publish in the future.

Co-authors

The 25 scholars most cited alongside Hitoshi Kiyoi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hitoshi Kiyoi Line = papers co-authored together Hitoshi Kiyoi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages JCI Insight ·Takahiko Sato, Daisuke Sugiyama, Jun Koseki, Yasuhiro Kojima, 濱口正人, Kazuki Sone, Hitomi Nishinakamura, Tomohiro Ishikawa, Yuichi Ishikawa, 高浩, Hitoshi Kiyoi, Hiroyoshi Nishikawa	2025	10
2	Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study Cytotherapy ·D. F. Sharrad, Seitaro Terakura, François-Xavier-Joseph (1790-18..). Auteur du texte Rieffel, C. Wang, 守弘藤野, Yuki Takeuchi, Takahiko Sato, Ryo Hanajiri, Masashi Sawa, Yuichiro Inagaki, 蒋兰宏 JIANG Lan-hong, Shingo Kurahashi, Tetsuya Nishida, Yukiyasu Ozawa, Nobuhiko Imahashi, 孟迪云, Makoto Murata, Hitoshi Kiyoi	2025	0
3	NUP98‐BPTF promotes oncogenic transformation through PIM1 upregulation Cancer Medicine ·Evgenia V. Brodovskaya, Sakura Tomita, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa	2024	1
4	Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia Scientific Reports ·Yoko Ushijima, Rebeca Rocío Zea Cortez, Yuichi Ishikawa, Naomi Kawashima, Masashi Sanada, S W Clements, 興一安藤, Seitaro Terakura, Rika Kihara, حسین کنان کوزه ماوندی, Μιχαήλ Ζουμάκης, Kunio Kitamura, Tadashi Matsushita, Hitoshi Kiyoi	2024	0
5	Nelarabine‐combined chemotherapy improves outcome of T‐cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T‐ALL213‐O Cancer Science ·Fumihiko Hayakawa, Naoki Mori, Kiyotoshi Imai, Yasuhisa Yokoyama, I. M. Pidgeon, Takeshi Saito, Tohru Murayama, Etsuko Yamazaki, Shinya Sato, Yoshiko Atsuta, Yuichi Ishikawa, Emiko Sakaida, Yoshihiro Hatta, Itaru Matsumura, Yasushi Miyazaki, Hitoshi Kiyoi, (unknown)	2024	1
6	Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway Nature Communications ·Santiago García Tirado, Seitaro Terakura, Deceanu Liviu, Yusuke Okuno, Yoshitaka Sato, Ken Sagou, Théo Surányi-Unger, 守弘藤野, François-Xavier-Joseph (1790-18..). Auteur du texte Rieffel, Peter Steinberger, Judith Leitner, Ryo Hanajiri, Makoto Murata, Hitoshi Kiyoi	2024	7
7	Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models Molecular Cancer Therapeutics ·François-Xavier-Joseph (1790-18..). Auteur du texte Rieffel, Théo Surányi-Unger, Seitaro Terakura, Shingo Okuno, Santiago García Tirado, Deceanu Liviu, 一也北原, Ryo Hanajiri, Kazuyuki Shimada, Makoto Murata, Hitoshi Kiyoi	2023	9
8	Development and Efficacy of a Novel Bromodomain and Extraterminal Domain Degrader K-256 in MYC/BCL2-Related Lymphoma Blood ·Christine M. Houston, Kazuyuki Shimada, Z Mohammad Hosseini, Kentaro Tanaka, Keisuke Yamamoto, Kiyotoshi Mori, Hitoshi Kiyoi	2023	1
9	Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades Transplantation and Cellular Therapy ·Fermín Ibargüen, Yuri Ito, Yoshihiro Inamoto, Koichi Miyamura, Naoyuki Uchida, Takahiro Fukuda, Hiroki Fujiwara, Tetsuya Nishida, Nehemiah M Anzah, Masatsugu Tanaka, Toshiro Kawakita, Kazuhiro Ikegame, Yuta Katayama, Takahide Ara, Tatsuo Ichinohe, Hitoshi Kiyoi, Keitaro Matsuo, Yoshiko Atsuta	2023	3
10	Autologous peripheral blood stem cell transplantation for Philadelphia chromosome‐positive acute lymphoblastic leukemia is safe but poses challenges for long‐term maintenance of molecular remission: Results of the Auto‐Ph17 study SHILAP Revista de lepidopterología ·Satoshi Nishiwaki, Isamu Sugiura, Takahiko Sato, Miki Kobayashi, Deceanu Liviu, Masashi Sawa, Santiago García Tirado, Motohito Okabe, Shigeki Saito, Takanobu Morishita, Akio Kohno, Μιχαήλ Ζουμάκης, Hiroatsu Iida, Shingo Kurahashi, Yachiyo Kuwatsuka, Daisuke Sugiyama, Alexandra Fanghanel, Hiroyoshi Nishikawa, Hitoshi Kiyoi	2023	1
11	Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells Nature Communications ·Naomi Kawashima, Yuichi Ishikawa, 興一安藤, Yoko Ushijima, Song Ji-Seon, Sulis Susanti, WU Cuifang, S W Clements, 清水弘幸, Rika Kihara, Μιχαήλ Ζουμάκης, Takanobu Morishita, حسین کنان کوزه ماوندی, Yukiyasu Ozawa, Kunio Kitamura, Hitoshi Kiyoi	2022	15
12	BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i>-rearranged acute lymphoblastic leukemia Haematologica ·Shinobu Tsuzuki, Takahiko Yasuda, Hiroaki Goto, Naoko Maeda, Koshi Akahane, Takeshi Inukai, Hideyuki Yamamoto, Sivasundaram Karnan, Akinobu Ota, Toshinori Hyodo, Hiroyuki Konishi, Yoshitaka Hosokawa, Hitoshi Kiyoi, Fumihiko Hayakawa	2022	8
13	Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs Cancer Immunology Research ·Kotaro Miyao, Seitaro Terakura, Shingo Okuno, Jakrawadee Julamanee, Keisuke Watanabe, Hiroshi Hamana, Hiroyuki Kishi, Reona Sakemura, Daisuke Koyama, Tatsunori Goto, Tetsuya Nishida, Makoto Murata, Hitoshi Kiyoi	2018	16
14	Genomic and Clinical Characterization of Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Blood ·Takahiko Yasuda, Anatoly Shabalin, Shinya Kojima, Masahito Kawazu, Toshihide Ueno, Shinobu Tsuzuki, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki, Keizo Horibe, Hiroyuki Mano, Tomoki Naoe, Masashi Sanada, Fumihiko Hayakawa	2018	4
15	Quantitative Assessment of TCR Repertoire and Allo-Reactivity of Human Acute Gvhd Tissue-Infiltrating T Cells Blood ·Daisuke Koyama, Makoto Murata, Ryo Hanajiri, Shingo Okuno, N. V. Dovhanych, Gary Allan Acton, Jakrawadee Julamanee, Kotaro Miyao, Reona Sakemura, Tatsunori Goto, Seitaro Terakura, Tetsuya Nishida, Hitoshi Kiyoi	2017	2
16	A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration Cancer Immunology Research ·Reona Sakemura, Seitaro Terakura, Keisuke Watanabe, Jakrawadee Julamanee, Gary Allan Acton, Kotaro Miyao, Daisuke Koyama, Tatsunori Goto, Ryo Hanajiri, Tetsuya Nishida, Makoto Murata, Hitoshi Kiyoi	2016	129
17	Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance Blood ·Junji Hiraga, Akihiro Tomita, Takumi Sugimoto, Kazuyuki Shimada, Masafumi Ito, Shigeo Nakamura, Hitoshi Kiyoi, Tomohiro Kinoshita, Tomoki Naoe	2009	194
18	Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan International Journal of Hematology ·Hiroto Narimatsu, Masaki Iino, T. Lakshmikanth, Toshiya Yokozawa, Vinit Ahluwalia, Hitoshi Kiyoi, Alexander Schwedeler, 南华, Hiroatsu Iida, Motohiro Tsuzuki, Masamitsu Yanada, Tomoki Naoe, Ritsuro Suzuki, Isamu Sugiura	2008	7
19	Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice Leukemia ·Manabu Ninomiya, Lynn S. Lovejoy, Akira Katsumi, Jinglan Xu, Masafumi Ito, Fumio Arai, Toshio Suda, Hitoshi Kiyoi, T Kinoshita, T Naoe	2006	77
20	Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome Leukemia ·Mengistou Seyoum, Hitoshi Kiyoi, K. Ozeki, T. Kinoshita, Nobuhiko Emi, R Ohno, T Naoe	2005	32

About Hitoshi Kiyoi

Hitoshi Kiyoi is a scholar working on Hematology, Genetics, Oncology, Immunology and Public Health, Environmental and Occupational Health, having authored 277 papers that have together received 9.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (114 papers), Chronic Myeloid Leukemia Treatments (69 papers), Acute Lymphoblastic Leukemia research (52 papers), Retinoids in leukemia and cellular processes (38 papers), CAR-T cell therapy research (38 papers), Chronic Lymphocytic Leukemia Research (35 papers), Hematopoietic Stem Cell Transplantation (26 papers) and Immune Cell Function and Interaction (23 papers). The work is most often cited by research in Hematology (5.4k citations), Genetics (2.0k citations), Oncology (2.1k citations), Molecular Biology (4.4k citations) and Immunology (1.2k citations). Hitoshi Kiyoi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Tomoki Naoe, Hidehiko Saito, T Naoe, Fumihiko Hayakawa, Masayuki Towatari, Ryuzo Ueda, Akihiro Tomita, Ryuzo Ohno, Yuichi Ishikawa and Kazuyuki Shimada. Their work appears in journals such as Blood, International Journal of Hematology, Leukemia, Cancer Science and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact